Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Interstellar comet 3I/ATLAS exhibits a bright, extended ion tail while releasing gas and dust as it travels through the inner solar system. When you purchase through links on our site, we may earn an ...

The mysterious Manhattan-sized interstellar object 3I/ATLAS appears to have no cometary tail in new images, which would eliminate the conventional explanation for the surprising “non-gravitational ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Recursion Pharmaceuticals, Inc. is one of them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a ...

A new image shows the growing tail of a comet from another star system streaking across our solar system. The image of comet 3I/ATLAS was captured on Aug. 27 using one of the telescopes at the ...

Comet 3I/ATLAS is just the third observed interstellar object ever witnessed in Earth's solar system. The Gemini South telescope in Chile is the latest observatory to get a glimpse of the object as it ...

"We were excited to see the growth of the tail, suggesting a change in the particles from the previous Gemini images." When you purchase through links on our site, we may earn an affiliate commission.